{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:48:51Z","timestamp":1791568131187,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.abd.2023.12.010","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T16:02:09Z","timestamp":1731081729000},"page":"104-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["DRESS syndrome: an interaction between drugs, latent viruses, and the immune system"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-6099","authenticated-orcid":false,"given":"Paulo Ricardo","family":"Criado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-3128","authenticated-orcid":false,"given":"Mayra","family":"Ianhez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9294","authenticated-orcid":false,"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2482-3047","authenticated-orcid":false,"given":"Roberta Fachini Jardim","family":"Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-069X","authenticated-orcid":false,"given":"Carolina","family":"Talhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-414X","authenticated-orcid":false,"given":"Paulo","family":"M\u00fcller Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.12.010_bib0005","first-page":"577","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system","volume":"14","author":"Criado","year":"2012","journal-title":"Isr Med Assoc J."},{"key":"10.1016\/j.abd.2023.12.010_bib0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg."},{"key":"10.1016\/j.abd.2023.12.010_bib0015","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.1937.92780500006011c","article-title":"Exfoliative dermatitis following sulfanilamide","volume":"109","author":"Myers","year":"1937","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.abd.2023.12.010_bib0020","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/jama.1938.02790380010004","article-title":"Sodium diphenyl hydantoinate in the treatment of convulsive disorders","volume":"111","author":"Merritt","year":"1938","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.abd.2023.12.010_bib0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(00)61376-4","article-title":"Treatment of epilepsy with sodium diphenyl hydantoinate","volume":"235","author":"Coope","year":"1940","journal-title":"Lancet."},{"key":"10.1016\/j.abd.2023.12.010_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jama.1946.02870360013003","article-title":"Fatal aplastic anemia following use of tridione and a hydantoin","volume":"132","author":"Harrison","year":"1946","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.abd.2023.12.010_bib0035","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.1958.72990300001010","article-title":"Lymphadenopathy induced by ethotoin (peganone); clinical and pathological mimicking of malignant lymphoma","volume":"167","author":"Saltzstein","year":"1958","journal-title":"J Am Med Assoc."},{"key":"10.1016\/j.abd.2023.12.010_bib0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM195006082422304","article-title":"Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis","volume":"242","author":"Chaiken","year":"1950","journal-title":"N Engl J Med."},{"key":"10.1016\/j.abd.2023.12.010_bib0045","first-page":"181","article-title":"The chemotherapy of leprosy in Nigeria; with an appendix on glandular fever and exfoliative dermatitis precipitated by sulfones","volume":"17","author":"Lowe","year":"1949","journal-title":"Int J Lepr."},{"key":"10.1016\/j.abd.2023.12.010_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(51)91443-2","article-title":"Toxic effects of diaminodiphenylsulphone in treatment of leprosy","volume":"2","author":"Allday","year":"1951","journal-title":"Lancet."},{"key":"10.1016\/j.abd.2023.12.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: a literature review and treatment algorithm","volume":"16","author":"Calle","year":"2023","journal-title":"World Allergy Organ J."},{"key":"10.1016\/j.abd.2023.12.010_bib0060","first-page":"139","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management","volume":"16","author":"Shiohara","year":"2017","journal-title":"Expert Opin Drug Saf."},{"key":"10.1016\/j.abd.2023.12.010_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.47892\/rgp.2022.422.1344","article-title":"Adverse reactions to antituberculosis drugs presenting as DRESS syndrome and acute liver failure","volume":"42","author":"Carlin Ronquillo","year":"2022","journal-title":"Rev Gastroenterol Peru."},{"key":"10.1016\/j.abd.2023.12.010_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4168\/aair.2019.11.1.90","article-title":"Prevalence and clinical features of drug reactions with eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs: a retrospective cohort study","volume":"11","author":"Jung","year":"2019","journal-title":"Allergy Asthma Immunol Res."},{"key":"10.1016\/j.abd.2023.12.010_bib0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0080","article-title":"Drug-induced reaction with eosinophilia and systemic symptoms: a review","volume":"15","author":"Alotaibi","year":"2023","journal-title":"Cureus."},{"key":"10.1016\/j.abd.2023.12.010_bib0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts","volume":"87","author":"Criado","year":"2012","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.abd.2023.12.010_bib0095","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/biomedicines10050999","article-title":"Drug reaction with eosinophilia and systemic symptoms (DReSS)\/drug-induced hypersensitivity syndrome (DiHS)-readdressing the DReSS","volume":"10","author":"Stirton","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.abd.2023.12.010_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/biomedicines11010177","article-title":"Delayed drug hypersensitivity reactions: molecular recognition, genetic susceptibility, and immune mediators","volume":"11","author":"Chu","year":"2023","journal-title":"Biomedicines."},{"key":"10.1016\/j.abd.2023.12.010_bib0105","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1034\/j.1398-9995.2002.02161.x","article-title":"Pathogenesis of drug-induced exanthems","volume":"57","author":"Pichler","year":"2002","journal-title":"Allergy."},{"key":"10.1016\/j.abd.2023.12.010_bib0110","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-nduced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.abd.2023.12.010_bib0115","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/jdv.19425","article-title":"Retrospective study on the association of human herpesvirus reactivation with severe DRESS: a description of blood and skin reactivations","volume":"37","author":"Marcombes","year":"2023","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.12.010_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome","volume":"30","author":"Cabanas","year":"2020","journal-title":"J Investig Allergol Clin Immunol."},{"key":"10.1016\/j.abd.2023.12.010_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.597761","article-title":"The roles of immunoregulatory networks in severe drug hypersensitivity","volume":"12","author":"Hsu","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2023.12.010_bib0130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2021.04.020","article-title":"Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: facial edema aligns to the severe phenotype","volume":"85","author":"Momen","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0135","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review","volume":"10","author":"Manieri","year":"2023","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.abd.2023.12.010_bib0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","article-title":"Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report","volume":"26","author":"Kim","year":"2020","journal-title":"Nat Med."},{"key":"10.1016\/j.abd.2023.12.010_bib0145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","article-title":"JAK-STAT pathway inhibitors in dermatology","volume":"98","author":"Miot","year":"2023","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0150","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med."},{"key":"10.1016\/j.abd.2023.12.010_bib0155","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"DRESS and AGEP reactions to iodinated contrast media: a french case series","volume":"9","author":"Soria","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.abd.2023.12.010_bib0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int."},{"key":"10.1016\/j.abd.2023.12.010_bib0165","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/bjd.14704","article-title":"Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward","volume":"175","author":"Pinto Gouveia","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s13671-021-00348-z","article-title":"Updates and insights in the diagnosis and management of DRESS syndrome","volume":"10","author":"Schunkert","year":"2021","journal-title":"Curr Dermatol Rep."},{"key":"10.1016\/j.abd.2023.12.010_bib0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/pde.14044","article-title":"Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature","volume":"37","author":"Metterle","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaad.2009.08.050","article-title":"Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients","volume":"63","author":"Ang","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clindermatol.2005.02.001","article-title":"Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000475802","article-title":"Overlapping DRESS and Stevens-Johnson syndrome: case report and review of the literature","volume":"9","author":"Casagranda","year":"2017","journal-title":"Case Rep Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0195","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7863815","article-title":"Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"2019","author":"Taweesedt","year":"2019","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.abd.2023.12.010_bib0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0205","first-page":"3","article-title":"Cardiac involvement in DRESS syndrome","volume":"35","author":"Thongsri","year":"2017","journal-title":"Asian Pac J Allergy Immunol."},{"key":"10.1016\/j.abd.2023.12.010_bib0210","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DAD.0000000000000439","article-title":"Histopathology of the exanthema in DRESS is not specific but may indicate severity of systemic involvement","volume":"38","author":"Goncalo","year":"2016","journal-title":"Am J Dermatopathol."},{"key":"10.1016\/j.abd.2023.12.010_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40257-018-00416-4","article-title":"Drug Reaction with eosinophilia and systemic symptoms (DReSS): how far have we come?","volume":"20","author":"Martinez-Cabriales","year":"2019","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0225","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/ijms22042147","article-title":"Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2023.12.010_bib0230","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0378-6323.74964","article-title":"Drug hypersensitivity syndrome","volume":"77","author":"Kumari","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.abd.2023.12.010_bib0240","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000487670","article-title":"C-Reactive protein and procalcitonin in case reports of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"176","author":"Hubner","year":"2018","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.abd.2023.12.010_bib0245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4168\/aair.2014.6.3.216","article-title":"Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy Asthma Immunol Res."},{"key":"10.1016\/j.abd.2023.12.010_bib0250","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.clindermatol.2020.06.008","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"38","author":"Cardones","year":"2020","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0255","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int."},{"key":"10.1016\/j.abd.2023.12.010_bib0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/idoj.idoj_196_21","article-title":"RegiSCAR DRESS (drug reaction with eosinophilia and systemic symptoms) validation scoring system and Japanese consensus group criteria for atypical drug-induced hypersensitivity syndrome (DiHS): a comparative analysis","volume":"13","author":"Sasidharanpillai","year":"2022","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.abd.2023.12.010_bib0270","article-title":"An updated review of the diagnostic methods in delayed drug hypersensitivity","volume":"11","author":"Copaescu","year":"2020","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.abd.2023.12.010_bib0275","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/ddg.13956","article-title":"S3 guidelines: epicutaneous patch testing with contact allergens and drugs - short version, part 1","volume":"17","author":"Mahler","year":"2019","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.abd.2023.12.010_bib0280","first-page":"1187","article-title":"S3 Guidelines: epicutaneous patch testing with contact allergens and drugs - short version, part 2","volume":"17","author":"Mahler","year":"2019","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.abd.2023.12.010_bib0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European society of contact dermatitis guideline for diagnostic patch testing - recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.abd.2023.12.010_bib0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cod.14090","article-title":"Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): a literature review","volume":"86","author":"de Groot","year":"2022","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.abd.2023.12.010_bib0295","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.0105-1873.2004.00340.x","article-title":"Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel","volume":"50","author":"Anveden","year":"2004","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.abd.2023.12.010_bib0300","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1600-0536.2009.01695.x","article-title":"Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors","volume":"62","author":"Wee","year":"2010","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.abd.2023.12.010_bib0305","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12016-022-08924-2","article-title":"The role of patch testing in evaluating delayed hypersensitivity reactions to medications","volume":"62","author":"Woodruff","year":"2022","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.abd.2023.12.010_bib0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cod.14063","article-title":"Skin tests in the work-up of cutaneous adverse drug reactions: a review and update","volume":"86","author":"Barbaud","year":"2022","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.abd.2023.12.010_bib0315","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bjd.17835","article-title":"Are drug intradermal tests dangerous to explore cross-reactivity and co-sensitization in DRESS?","volume":"181","author":"Soria","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0320","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy."},{"key":"10.1016\/j.abd.2023.12.010_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113036","article-title":"Lymphocyte transformation test: history and current approaches","volume":"493","author":"Sachs","year":"2021","journal-title":"J Immunol Methods."},{"key":"10.1016\/j.abd.2023.12.010_bib0330","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00431-021-04010-5","article-title":"Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after beta-lactams intake: a diagnostic challenge","volume":"180","author":"Dondi","year":"2021","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.abd.2023.12.010_bib0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5327\/Z2447-211520171700045","article-title":"DRESS syndrome in the aged: a differential diagnosis to be considered","volume":"11","author":"Garuzi","year":"2017","journal-title":"Geriatr Gerontol Aging."},{"key":"10.1016\/j.abd.2023.12.010_bib0340","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000069956","article-title":"Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update","volume":"206","author":"Tas","year":"2003","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2023.12.010_bib0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdcr.2023.07.025","article-title":"A diagnostic challenge: life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion","volume":"39","author":"Elkady","year":"2023","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.abd.2023.12.010_bib0350","article-title":"Drug-induced hypersensitivity syndrome: a clinical, radiologic, and histologic mimic of lymphoma","volume":"2018","author":"Gowani","year":"2018","journal-title":"Case Rep Hematol."},{"key":"10.1016\/j.abd.2023.12.010_bib0355","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.5858\/arpa.2021-0087-OA","article-title":"Morphologic spectrum of lymphadenopathy in drug reaction with eosinophilia and systemic symptoms syndrome","volume":"146","author":"Chen","year":"2022","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.abd.2023.12.010_bib0360","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/ced.14667","article-title":"Erythroderma (exfoliative dermatitis). Part 2: energy homeostasis and dietetic management strategies","volume":"46","author":"Tso","year":"2021","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0365","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ced.14625","article-title":"Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis","volume":"46","author":"Tso","year":"2021","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0370","series-title":"StatPearls [Internet]","article-title":"Exfoliative dermatitis","author":"Austad","year":"2023"},{"key":"10.1016\/j.abd.2023.12.010_bib0375","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II. Diagnosis and management","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0380","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.annder.2021.02.002","article-title":"Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): a monocenter retrospective study of 20 cases","volume":"148","author":"Brin","year":"2021","journal-title":"Ann Dermatol Venereol."},{"key":"10.1016\/j.abd.2023.12.010_bib0385","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1684\/ejd.2011.1300","article-title":"Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone","volume":"21","author":"Natkunarajah","year":"2011","journal-title":"Eur J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0390","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/1346-8138.16230","article-title":"Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan","volume":"49","author":"Hashizume","year":"2022","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0395","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0400","doi-asserted-by":"crossref","DOI":"10.2196\/41391","article-title":"Cyclosporine in the treatment of drug reaction with eosinophilia and systemic symptoms syndrome: retrospective cohort study","volume":"6","author":"Zita","year":"2023","journal-title":"JMIR Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2023.4450","article-title":"Management of adult patients with drug reaction with eosinophilia and systemic symptoms: a delphi-based international consensus","volume":"160","author":"Bruggen","year":"2024","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0410","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/ijd.14174","article-title":"Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement","volume":"57","author":"Intarasupht","year":"2018","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2023.12.010_bib0415","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol Int."},{"key":"10.1016\/j.abd.2023.12.010_bib0420","article-title":"A fatal presentation of DRESS syndrome with multiple visceral failure mimicking septic shock","volume":"79","author":"Lafkih","year":"2022","journal-title":"Ann Med Surg (Lond)."},{"key":"10.1016\/j.abd.2023.12.010_bib0425","doi-asserted-by":"crossref","first-page":"193","DOI":"10.36518\/2689-0216.1499","article-title":"Death due to drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report","volume":"4","author":"Sternad","year":"2023","journal-title":"HCA Healthc J Med."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624002071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624002071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:00:51Z","timestamp":1747652451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624002071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0365059624002071"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.12.010","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DRESS syndrome: an interaction between drugs, latent viruses, and the immune system","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}